OFS
DNTH icon

OneAscent Financial Services’s Dianthus Therapeutics DNTH Stock Holding History

OneAscent Financial Services’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-785
Closed -$190K – 164
2019
Q4 		$190K Buy
+785
New +$147K 0.11% 159
2019
Q3 		– Sell
-702
Closed -$166K – 68
2019
Q2 		$166K Buy
+702
New +$174K 0.11% 205

Other funds holding DNTH

TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

OneAscent Financial Services's DNTH Position: Q1 2020 in Review

OneAscent Financial Services sold out of Dianthus Therapeutics (DNTH) in Q1 2020, closing a stake of 785 shares — an estimated $190K sold.

OneAscent Financial Services first reported a position in DNTH in Q2 2019 and held it in 2 quarters. The position peaked at $190K in Q4 2019. 72 funds tracked by Wall St. Rank hold DNTH as of Q1 2020.

  • OneAscent Financial Services reported no remaining Dianthus Therapeutics position as of Q1 2020 after selling out during the quarter.
  • OneAscent Financial Services sold 785 Dianthus Therapeutics shares in Q1 2020, an estimated $190K.
  • OneAscent Financial Services first reported a position in Dianthus Therapeutics in Q2 2019 and held it in 2 quarters.
  • OneAscent Financial Services's Dianthus Therapeutics position peaked at $190K in Q4 2019.
  • 72 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2020.

Based on OneAscent Financial Services's 13F filing for Q1 2020, filed 14 Apr 2020.